These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3481330)

  • 1. Pharmacokinetics of ofloxacin in patients on haemodialysis treatment.
    Dörfler A; Schulz W; Burkhardt F; Zichner M
    Drugs; 1987; 34 Suppl 1():62-70. PubMed ID: 3481330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preliminary report on the pharmacokinetics of ofloxacin, desmethyl ofloxacin and ofloxacin N-oxide in patients with chronic renal failure.
    White LO; MacGowan AP; Lovering AM; Reeves DS; Mackay IG
    Drugs; 1987; 34 Suppl 1():56-61. PubMed ID: 3481329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ofloxacin pharmacokinetics in patients on continuous ambulatory peritoneal dialysis.
    Chan MK; Chau PY; Chan WW
    Clin Nephrol; 1987 Dec; 28(6):277-80. PubMed ID: 3481692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion of ofloxacin into human lung tissue.
    Couraud L; Fourtillan JB; Saux MC; Bryskier A; Vincent du Laurier M
    Drugs; 1987; 34 Suppl 1():37-8. PubMed ID: 3481326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of ofloxacin from blood to sputum.
    Davies BI; Maesen FP; Geraedts WH; Baur C
    Drugs; 1987; 34 Suppl 1():26-32. PubMed ID: 3481324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary tract excretion of ofloxacin in man.
    Kazmierczak A; Pechinot A; Duez JM; Haas O; Favre JP
    Drugs; 1987; 34 Suppl 1():39-43. PubMed ID: 3481327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agent.
    Dagrosa EE; Verho M; Malerczyk V; de Looze S; Hajdú P; Toyodera K
    Clin Ther; 1986; 8(6):632-45. PubMed ID: 3466701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of ofloxacin into bronchial secretions.
    Symonds J; Bone M; Turner A; Javaid A
    Drugs; 1987; 34 Suppl 1():33-6. PubMed ID: 3481325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of ofloxacin, desmethyl ofloxacin and ofloxacin N-oxide in haemodialysis patients with end-stage renal failure.
    White LO; MacGowan AP; Mackay IG; Reeves DS
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():65-72. PubMed ID: 3182464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ofloxacin and adequacy of maintenance dose for patients on haemodialysis.
    Kampf D; Borner K; Pustelnik A
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():61-8. PubMed ID: 2286592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ofloxacin and theophylline alone and in combination.
    Fourtillan JB; Granier J; Saint-Salvi B; Salmon J; Surjus A; Tremblay D; Vincent Du Laurier M; Beck S
    Infection; 1986; 14 Suppl 1():S67-9. PubMed ID: 3456985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R; Griggs D; Andrews JM
    Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetics of ciprofloxacin and ofloxacin in cystic fibrosis patients.
    Pedersen SS; Jensen T; Hvidberg EF
    J Antimicrob Chemother; 1987 Oct; 20(4):575-83. PubMed ID: 3479419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of a new oral antibacterial agent, ofloxacin, in dentistry and oral surgery.
    Bedeschi G; Beltrame M; Baldin C; Confente G; Guerra L; Fostini R
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):162-4. PubMed ID: 3165967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian pharmacokinetics of gentamicin in a haemodialysis population.
    Vercaigne LM; Ariano RE; Zacharias JM
    Clin Pharmacokinet; 2004; 43(3):205-10. PubMed ID: 14871157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of once-daily oral 400 mg ofloxacin in patients with peritonitis complicating continuous ambulatory peritoneal dialysis.
    McMullin CM; Brown NM; Brown IM; Tomson CR; White LO; Reeves DS; MacGown AP
    J Antimicrob Chemother; 1997 Jun; 39(6):829-31. PubMed ID: 9222057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple dose kinetics of ofloxacin and ofloxacin metabolites in haemodialysis patients.
    Kampf D; Borner K; Pustelnik A
    Eur J Clin Pharmacol; 1992; 42(1):95-9. PubMed ID: 1541323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of ofloxacin in the elderly (65-85 years) with normal renal function after a single oral dose of 200 mg].
    Veyssier P; Fourtillan JB; Modai J; Couet W; Lefebvre MA; Darchis JP; Vincent Du Laurier M; Bryskier A
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):596-9. PubMed ID: 3534750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetics of new quinolones.
    Lode H; Höffken G; Prinzing C; Glatzel P; Wiley R; Olschewski P; Sievers B; Reimnitz D; Borner K; Koeppe P
    Drugs; 1987; 34 Suppl 1():21-5. PubMed ID: 3481323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue concentrations of ofloxacin in the middle ear.
    Thorn V
    Clin Ther; 1987; 9(5):523-7. PubMed ID: 3478138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.